Abstract
Objective
To assess the association between coenzyme Q10 (CoQ10) intake from food sources and semen quality. We assessed this association in a prospective cohort of men attending a fertility clinic. CoQ10 supplementation has been associated with improvements in semen parameters. However, impact of CoQ10 intake from food sources on semen quality has not been investigated.
Methods
Subfertile couples seeking fertility evaluation at the Massachusetts General Hospital Fertility Center were invited to participate in an ongoing study of environmental factors and fertility. In total, 211 male participants completed a validated food frequency questionnaire and provided 476 semen samples. Multivariable linear mixed models were used to examine the relation between CoQ10 intake from foods and semen parameters while adjusting for potential confounders and accounting for within-person correlations.
Results
Mean dietary CoQ10 intake was 19.2 mg/day (2.4–247.2 mg/day). No subjects were taking CoQ10 supplements. There were no associations between dietary CoQ10 intake from foods and conventional semen parameters. The adjusted mean difference (95% confidence interval) comparing men in the top and bottom quartiles of CoQ10 intake from foods were −3.1 mil/mL (95% CI −29.5, 38.8 mil/mL) for sperm concentration, −4.5% (−15.1%, 6.0%) for total motility, −1.3% for progressive motility (−8.4%, 5.7%) and 0.3% (−1.4%, 2.0%) for sperm morphology.
Conclusions
CoQ10 intake from foods was not related to semen parameters among subfertile men. Mean dietary intake of CoQ10 in this study was 10-fold lower than the supplemental dose used in clinical trials showing improved sperm motility. CoQ10 intake from foods alone may be insufficient to optimize semen parameters.
Keywords: Semen Analysis, Coenzyme Q10, Infertility, Male, Spermatozoa, Diet Records
Introduction
Coenzyme Q10 (CoQ10) is a fat-soluble ubiquinone that plays a critical role in both cellular energy metabolism at the mitochondrial level and as an antioxidant for cell membranes and lipoproteins. Approximately half of the body’s CoQ10 is obtained through diet and the remainder is endogenously synthesized via the cholesterol metabolic pathway1, 2. In sperm, CoQ10 is concentrated in the mitochondria-containing midpiece where it is involved in all energy-dependent processes, including sperm motility3. CoQ10 also acts as an antioxidant, preventing lipid peroxidation of sperm cell membranes4. Oxidative stress may negatively affect sperm by peroxidation of the polyunsaturated lipid present in high concentrations in the cell membrane5. Sperm cell membrane fluidity and integrity may be compromised, leading to increased permeability; this, in turn, may result in impaired sperm motility, abnormal morphology, increased DNA fragmentation and/or impaired acrosome reaction6.
The protective effects of supplemental CoQ10 on sperm have been amply documented. In vitro incubation of spermatozoa with impaired motility in a CoQ10-enriched medium improves motility3. Several clinical trials used oral CoQ10 supplementation ranging from 200–600 mg/day in an effort to improve semen parameters in subfertile men (7–10), noting improvements in sperm concentrations, motility, and total motile sperm counts. Furthermore, higher seminal fluid concentrations of CoQ10 are correlated with higher sperm concentrations and motility7.
Whether these improvements in semen parameters translate to higher rates of conception is unclear. A recent meta-analysis including 3 randomized controlled trials revealed that CoQ10 supplementation increases CoQ10 concentration in seminal fluid and improves sperm concentration and motility. However, only one of those studies reported spontaneous conception outcomes; that study did not demonstrate a significant difference in pregnancy rates between the treated and placebo groups8.
CoQ10 is acquired not only by supplementation, but also from a normal diet. Major dietary sources of CoQ10 include meats, fish, nuts, vegetable oils (and foods fried in these oils), and much lower levels of CoQ10 can be found in most dairy products, vegetables, fruits, and cereals9, 10. Previous data from the Environment and Reproductive Health (EARTH) Study demonstrated improved sperm motility in association with higher intake of organ meats11, which are very high in CoQ10. To our knowledge, the relationship of CoQ10 intake from foods to semen parameters has not yet been evaluated. Given the findings in the literature related to supplemental oral CoQ10, we hypothesized that higher CoQ10 intake from foods would be associated with improved conventional semen parameters.
Materials and Methods
Study Population
Men presenting to the Massachusetts General Hospital Fertility Center for fertility evaluation were invited to participate in the EARTH Study, an ongoing study assessing environmental factors and how they relate to fertility12. Men ages 18 to 55 years, without history of vasectomy, were eligible for recruitment. A food frequency questionnaire (FFQ) was introduced as part of the EARTH study in April, 2007, and was completed by 248 of the 405 men (61%) recruited through September 2015. Of these, 234 men produced at least one semen sample after completion of the FFQ. We excluded men with incomplete semen analysis data (n=11) or incomplete anthropometric data (n=1). Semen samples collected more than 18 months after FFQ completion (73 samples from 11 men) were excluded from the analysis in order to minimize any influence related to changes in dietary habits over time. After exclusions, 211 men provided a total of 476 semen samples (See Figure 1): 76 men provided 1 sample, 69 men provided 2 samples, and 66 men provided ≥3 samples; the maximum number of samples per subject was 9.
Figure 1.

Patient Accrual
At enrollment, trained research nurses administered a general health questionnaire querying patient demographics, lifestyle/behavioral habits, and reproductive history, and also performed an anthropometric assessment. The study was approved by the human subject committees of the Harvard T.H. Chan School of Public Health and the Massachusetts General Hospital. Written informed consent was obtained from all participants before enrollment.
Dietary Assessment
Participants completed a validated 131-item FFQ13. Men were asked to report how often, on average, they had consumed specified amounts of foods, beverages, and nutritional supplements during the previous year. Nutrient intakes were derived by summing specific contributions across all food items in the questionnaire using the United States Department of Agriculture (USDA) nutrient database and additional information obtained from manufacturers. Multivitamin and supplement use (including CoQ10 supplementation) at the time of the survey or within the previous year was also recorded.
The USDA database does not include data on CoQ10 content in foods. Therefore, CoQ10 content of each dietary item was determined based on values in the published literature9, 14–16. For foods for which published CoQ10 contents were unavailable, an estimated contribution was calculated based on the food item most similar to the unavailable item (e.g., “cream cheese” considered as “other cheese”) or proportionally to the fat content in the main dietary component contained within the item (e.g., “ice cream” as “whole milk”). As CoQ10 is obtained through fat-containing foods, beverages (except milk), were not considered as they do not contain significant amounts of CoQ10. Dietary CoQ10 intake was derived by summing CoQ10 contribution from each item of the FFQ. The top food contributors to intake in this population were meat and poultry (27.3%), edible fat (25.0%) and foods fried in vegetable oils (22.3%). (Figure 2)
Figure 2.

Contribution of each food group
Semen Analyses
Semen samples were obtained on-site by masturbation and collected into an Andrology laboratory-approved sterile plastic specimen container. Men were instructed to abstain from ejaculation for at least 48 hours but no longer than 5 days prior to sample production and to report the abstinence interval; 37 men (45 semen samples) did not report their last ejaculation date and were assigned to the most common abstinence interval (2–3 d). Semen samples were liquefied at 37°C for 20 min before analysis in accordance with World Health Organization standards17. Sperm concentration and motility were assessed with a computer-aided semen analysis system (Ceros, version 14; Hamilton-Thorne Biosciences). Results for sperm motility were expressed as percentage of total and progressively motile spermatozoa18. Sperm morphology was determined by using Kruger strict criteria and results were expressed as percentage of normal spermatozoa10.
Statistical Analysis
Continuous variables were presented as mean and standard deviation (SD), whereas discrete variables were described using counts and percentages. The cohort was divided into quartiles of CoQ10 intake for statistical analysis. Tests of association between subject characteristics and CoQ10 intake were performed using the Kruskal-Wallis test for continuous variables and the chi-squared test for categorical variables. Linear mixed models were used to evaluate the relationship of CoQ10 intake with semen parameter categories while adjusting for potential confounders and accounting for within-person correlations in semen parameters across repeated samples.
The association between CoQ10 intake and semen parameters was also evaluated as continuous linear and quadratic variables. We considered as potential confounders variables previously associated with semen quality including age, BMI, total fat intake, caffeine intake, alcohol intake, smoking status, race, abstinence interval and male factor diagnosis. Sperm concentration was log-transformed to more closely approximate a normal distribution and back transformed to be presented in original scale. All results are presented as adjusted means for the median level of each covariate.
To address the possibility that fried foods may have lost a percentage of their original CoQ10 content during the frying process, we conducted a sensitivity analysis where we multiplied their original CoQ10 levels by 0.68 (which represents a 32% degradation based on previous research)23. In addition, we conducted a separate sensitivity analysis excluding semen samples from men who did not report their abstinence interval prior to sample collection. Effect modification by BMI, smoking status (current and never/former smokers), and race (white and other) were tested using cross-product terms in the final multivariate model. All statistical analyses were carried out using SAS Statistical Software, Version 9.04 (SAS Institute Inc. Cary, North Carolina, USA).
Results
Mean age of the cohort was 36.5 ± 4.7 years with a mean BMI of 27.1 ± 3.9 kg/m2. The vast majority of men were Caucasian (89%). Most men had never smoked (65%) with only 5% (10 men) reporting to be current smokers. More than one-third of men (36%) had been diagnosed with at least a contributing male factor to the couple’s infertility. Mean daily CoQ10 intake from foods was 19.2 mg/d ranging from 2.38 to 247.16 mg/d. Median (IQR) sperm concentration was 71.6 (74.8) mil/mL while mean total motility and progressive motility were 46.3% ± 22.4 and 26.4% ± 14.4, respectively. Mean percent normal morphology was 6.4% ± 3.4. CoQ10 intake was positively related to calorie, meat, dairy, fat and alcohol intakes. There were no other differences in baseline characteristics across quartiles of CoQ10 intake (Table 1).
Table 1.
Baseline demographic and dietary characteristics in relation to quartile of dietary CoQ10 intake
| Quartiles of Total CoQ10 Intake | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cohort | Quartile 1 (Lowest) |
Quartile 2 | Quartile 3 | Quartile 4 (Highest) |
|||||||
| N = 211 | N = 52 | N = 53 | N = 53 | N = 53 | |||||||
| CoQ10 intake range (mg/day) |
2.4 – 247.2 | 2.4–10.1 | 10.1–15.4 | 15.4–20.8 | 20.8–247.2 | ||||||
|
N or Mean |
SD |
N or Mean |
SD |
N or Mean |
SD |
N or Mean |
SD |
N or Mean |
SD |
p value |
|
| Background characteristics | |||||||||||
| BMI (kg/m2) | 27.1 | 3.9 | 27.0 | 3.7 | 26.6 | 4.2 | 26.8 | 4.1 | 28.0 | 3.6 | 0.16 |
| Age (years) | 36.5 | 4.7 | 36.1 | 4.6 | 35.6 | 4.9 | 36.7 | 4.9 | 37.4 | 4.3 | 0.19 |
| Moderate/vigor ous exercise, hrs/wk |
5.7 | 8.8 | 5.7 | 13.5 | 5.1 | 7.6 | 6.8 | 7.4 | 5.2 | 4.3 | 0.16 |
| Sedentary Activity, hrs/wk |
46.5 | 24.7 | 45.3 | 25.8 | 48.2 | 22.0 | 44.4 | 28.8 | 48.2 | 21.8 | 0.86 |
| Total activity, METs/w |
46.4 | 63.3 | 46.8 | 103.7 | 42.2 | 42.6 | 50.0 | 48.6 | 46.5 | 37.7 | 0.24 |
| Race | 0.82 | ||||||||||
| White | 188 | 45 | 48 | 47 | 48 | ||||||
| Black | 6 | 2 | 1 | 1 | 2 | ||||||
| Asian | 11 | 2 | 2 | 4 | 3 | ||||||
| Latino | 6 | 3 | 2 | 1 | 0 | ||||||
| Smoking | 0.59 | ||||||||||
| Never Smoked |
138 | 33 | 32 | 37 | 36 | ||||||
| Past Smoker | 63 | 17 | 20 | 13 | 13 | ||||||
| Current Smoker |
10 | 2 | 1 | 3 | 4 | ||||||
| Reproductive Background | |||||||||||
| Presence of male factor infertility |
77 | 20 | 17 | 20 | 20 | 0.90 | |||||
| Previous infertility exam |
162 | 39 | 36 | 42 | 45 | 0.22 | |||||
| History of cryptorchidism |
9 | 2 | 2 | 1 | 4 | 0.52 | |||||
| Varicocele | 20 | 7 | 5 | 3 | 5 | 0.54 | |||||
| Previous reproductive surgery |
51 | 14 | 10 | 13 | 14 | 0.76 | |||||
| Abstinence time (hrs) |
85 | 380 | 77 | 158 | 137 | 554 | 75 | 123 | 38 | 475 | 0.09 |
| Diet | |||||||||||
| Calorie Intake (kcal/day) |
2015 | 655 | 1459 | 400 | 1858 | 477 | 2241 | 466 | 2492 | 717 | <0.01 |
| Total fat intake (g/day) |
70.9 | 27.3 | 46.9 | 14.0 | 64.2 | 17.6 | 78.1 | 18.8 | 93.9 | 30.6 | <0.01 |
| Calories from protein (%) |
16.4 | 3.0 | 16.8 | 3.3 | 16.4 | 2.4 | 16.1 | 3.6 | 16.4 | 2.8 | 0.71 |
| Calories from carbohydrates (%) |
48.9 | 8.1 | 51.4 | 9.6 | 48.6 | 6.6 | 48.7 | 8.8 | 47.0 | 6.7 | 0.08 |
| Calories from fat (%) |
31.6 | 5.8 | 29.4 | 6.5 | 31.3 | 4.9 | 31.7 | 6.1 | 33.8 | 4.7 | <0.01 |
| Meat intake (servings/day) |
1.5 | 0.8 | 1.0 | 0.5 | 1.3 | 0.5 | 1.6 | 0.6 | 2.0 | 1.0 | <0.01 |
| Dairy intake (servings/day) |
2.2 | 1.2 | 1.7 | 1.0 | 1.9 | 0.9 | 2.5 | 1.3 | 2.5 | 1.2 | <0.01 |
| Western Score | 0.0 | 1.0 | −0.5 | 0.8 | −0.2 | 0.9 | 0.1 | 0.9 | 0.6 | 1.1 | <0.01 |
| Prudent Score | 0.0 | 1.0 | −0.8 | 0.4 | −0.1 | 0.6 | 0.3 | 0.9 | 0.6 | 1.3 | <0.01 |
| Alcohol intake (g/day) |
14.2 | 16.6 | 8.9 | 10.1 | 14.1 | 13.0 | 17.2 | 22.5 | 16.3 | 17.1 | 0.01 |
| Caffeine intake (mg/day) |
183 | 124 | 164 | 112 | 174 | 119 | 188 | 142 | 205 | 122 | 0.29 |
Comparison of semen parameters including sperm concentration, total and progressive motility, and morphology by CoQ10 intake quartile did not yield any significant differences among intake groups (Table 2). Specifically, the multivariate adjusted mean (95% CI) total sperm motility across increasing quartiles of CoQ10 intake were 53.0% (43.3–62.8%), 50.4% (41.2–59.7%), 49.8% (40.5–59.1%), and 48.5% (37.9–59.0%) (p-trend=0.36). The multivariable adjusted mean sperm concentrations in mil/mL (95% CI) for men in increasing quartiles of CoQ10 intake were 74.3 (48.6–113.6), 66.2 (44.0–99.7), 81.6 (54.2–122.9), and 71.2 (44.8–113.1) (p-trend=0.96). No associations were seen with the semen parameters when CoQ10 was modeled as a continuous linear or quadratic variable (data not shown). The sensitivity analysis where we applied a correction factor to fried foods to account for possible CoQ10 degradation during the frying process did not yield any significant difference from the main analysis. furthermore, the results were similar in the sensitivity analysis where we excluded samples without abstinence interval. There was no evidence that an association between sperm concentration and CoQ10 intake from foods differed by BMI (p-interaction = 0.68), smoking status (p-interaction = 0.96) or race (p-interaction = 0.72).
Table 2.
Association between quartiles of dietary CoQ10 intake and semen parameters
| Quartiles of Total CoQ10 Intake | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Quartile 1 - (Lowest) Subject N = 52 Semen N = 119 |
Quartile 2 Subject N = 53 Semen N = 131 |
Quartile 3 Subject N = 53 Semen N = 124 |
Quartile 4 - (Highest) Subject N = 53 Semen N = 102 |
||||||
| CoQ10 intake range (mg/day) |
2.4–10.1 | 10.1–15.4 | 15.4–20.8 | 20.8–247.2 | |||||
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | p-trend | |
| Mixed Linear Models (Least Squares Means) | |||||||||
| Sperm concentration (mil/mL) |
74.3 | 48.6–113.6 | 66.2 | 44.0–99.7 | 81.6 | 54.2–122.9 | 71.2 | 44.8–113.1 | 0.96 |
| Total motility (%) | 53.0 | 43.3–62.8 | 50.4 | 41.2–59.7 | 49.8 | 40.5–59.1 | 48.5 | 37.9–59.0 | 0.36 |
| Progressive motility (%) | 31.3 | 24.8–37.8 | 30.4 | 24.3–36.6 | 28.4 | 22.3–34.6 | 30.0 | 22.9–37.0 | 0.69 |
| Normal morphology (%) | 6.4 | 4.9–8.0 | 6.8 | 5.3–8.3 | 6.3 | 4.8–7.7 | 6.7 | 5.0–8.4 | 0.84 |
Note -- mixed models adjusted for: presence of male factor infertility, age, BMI, race, smoking, physical activity, meat intake, dairy intake, prudent/western dietary patterns scores, calorie intake, caffeine intake, alcohol intake, total fat intake and abstinence interval
Discussion
CoQ10 is an endogenous cofactor that plays an essential role in the Krebs cycle reaction within mitochondria. It also serves as an antioxidant in seminal fluid, thought to protect the integrity of the sperm cell membrane from damaging reactive oxygen species19. A relative imbalance of the oxidative/antioxidant status of seminal fluid has been found in infertile men and is associated with impairments in all semen parameters20, 21. Although several clinical studies suggest a protective effect on sperm when supplemental CoQ10 is administered, our findings show that, in this cohort of male partners from subfertile couples, intake of CoQ10 from foods was not associated with conventional semen parameters.
The use of supplemental CoQ10 as an antioxidant and its effect on sperm has been demonstrated by several in vitro and clinical studies. Safarinejad et al. administered 600mg/day and observed improvements in sperm concentration, motility and morphology in 287 infertile men with oligoasthenospermia beginning at 3 months after initiation of supplementation22. The same researchers used 300mg daily of CoQ10 for 26 weeks in a different cohort of infertile men with abnormal pre-treatment semen parameters and again observed improvements in sperm concentration and motility23. Balercia et al. used a dose of 200mg/day for 6 months in infertile men with idiopathic oligoasthenospermia who had partners without apparent female factor. They observed an increase of serum CoQ10 levels in 50% of subjects and a coincident improvement in total motile sperm counts. Three months after cessation of CoQ10 supplementation, patients’ semen parameters returned to baseline24. Even using the reduced form of CoQ10, ubiquinol, Safarinejad et al. reported improvements in sperm concentration, motility and morphology of 228 infertile men with idiopathic oligoasthenoteratospermia25. Furthermore, higher seminal fluid concentrations of CoQ10 are correlated with higher sperm concentrations and motility7.
CoQ10 serum and semen concentrations are linearly correlated such that CoQ10 supplementation of 30 mg and 100 mg daily resulted in a 1.47- and 2.16-fold increase in plasma concentrations, respectively26. The linear correlation between the amount of CoQ10 supplementation and serum concentrations has been shown to be sustained until a dose of 2400mg/day, at which point a plateau in plasma concentration is achieved27.
In our cohort, no association between CoQ10 intake from foods and semen parameters was found. However, the mean CoQ10 intake from foods was 38.9mg/day even within the highest CoQ10 intake quartile. This intake is relatively low compared to the 200–600mg daily intake in the previously published CoQ10 supplement studies. This observation suggests that dietary intake of CoQ10 from foods alone may not be adequate to have an effect on semen parameters. To our knowledge, no group has previously reported on the relationship between CoQ10 intake from foods and possible impacts on semen parameters.
Despite the novel contribution of this study, it does have some limitations. The data are acquired from a questionnaire that depends on subjects recalling their eating habits in the last year. In addition, nutrient intake was calculated based on published studies9, 15, 16 which measured CoQ10 concentration in each food as opposed to using the USDA nutrient database. We also had to make specific assumptions about the CoQ10 content of certain foods as not all foods in the questionnaire had a documented CoQ10 value available in published literature. Of reassurance, however, is that the main dietary sources of CoQ10 intake are meats, fish, nuts and olive oils which all had published CoQ10 values available. Thus, dietary misclassification of CoQ10 intake is possible; however, because of the prospective nature of our study, any such misclassification would be expected to be non-differential. Given that we found no association between dietary CoQ10 intake from foods and semen quality parameters, the imprecision of our exposure measurement could be one explanation for these null findings. In addition, spermatogenesis is a continuous process and may be affected by changes in food intake. In order to minimize this possible effect, samples collected more than 18 months distant from FFQ completion were excluded from the analysis. A final aspect relates to our specific cohort, which is composed of men from subfertile couples seeking evaluation. Previous studies assessed the impact of CoQ10 supplementation specifically in infertile men22, 24. Our cohort, by default, included all men seeking assistance for couple’s infertility regardless of baseline semen parameters (including men with normal semen analyses). Therefore, it is possible that this heterogeneous population may not benefit from CoQ10 intake as much as those patients with distinct semen abnormalities.
Conclusions
In this study, CoQ10 intake from foods was not related to conventional semen parameters. It is important to note that the mean dietary intake of CoQ10 from foods was more than 10-fold lower than the supplemental 200–600mg daily doses used in previous controlled trials, which did demonstrate improvements in sperm concentrations and motility. The relatively low intake of CoQ10 from foods in our cohort may explain the discrepancy between our results and the findings of those supplement trials. Dietary CoQ10 intake from foods alone may not be sufficient to optimize semen parameters and further investigations regarding the role for CoQ10 supplementation are warranted.
Acknowledgments
Sources of Support: NIH Grants R01-ES009718 from NIEHS and P30-DK046200 and T32-DK007703-16 from NIDDK
We acknowledge all members of the EARTH study team, specifically the Harvard T. H. Chan School of Public Health research nurses Jennifer B. Ford and Myra G. Keller, research staff Ramace Dadd and Patricia Morey, physicians and staff at Massachusetts General Hospital Fertility Center. A special thank you is extended to all study participants.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Nohl H, Gille L, Staniek K. The biochemical, pathophysiological, and medical aspects of ubiquinone function. Annals of the New York Academy of Sciences. 1998;854:394–409. doi: 10.1111/j.1749-6632.1998.tb09919.x. [DOI] [PubMed] [Google Scholar]
- 2.Tran UC, Clarke CF. Endogenous synthesis of coenzyme Q in eukaryotes. Mitochondrion. 2007;7(Suppl):S62–S71. doi: 10.1016/j.mito.2007.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lewin A, Lavon H. The effect of coenzyme Q10 on sperm motility and function. Molecular aspects of medicine. 1997;18(Suppl):S213–S219. doi: 10.1016/s0098-2997(97)00036-8. [DOI] [PubMed] [Google Scholar]
- 4.Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochimica et biophysica acta. 2004;1660(1–2):171–199. doi: 10.1016/j.bbamem.2003.11.012. [DOI] [PubMed] [Google Scholar]
- 5.Saleh RA, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. Journal of andrology. 2002;23(6):737–752. [PubMed] [Google Scholar]
- 6.Jedrzejczak P, Fraczek M, Szumala-Kakol A, Taszarek-Hauke G, Pawelczyk L, Kurpisz M. Consequences of semen inflammation and lipid peroxidation on fertilization capacity of spermatozoa in in vitro conditions. International journal of andrology. 2005;28(5):275–283. doi: 10.1111/j.1365-2605.2005.00547.x. [DOI] [PubMed] [Google Scholar]
- 7.Alleva R, Scararmucci A, Mantero F, Bompadre S, Leoni L, Littarru GP. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Molecular aspects of medicine. 1997;18(Suppl):S221–S228. doi: 10.1016/s0098-2997(97)00040-x. [DOI] [PubMed] [Google Scholar]
- 8.Lafuente R, Gonzalez-Comadran M, Sola I, Lopez G, Brassesco M, Carreras R, et al. Coenzyme Q10 and male infertility: a meta-analysis. Journal of assisted reproduction and genetics. 2013;30(9):1147–1156. doi: 10.1007/s10815-013-0047-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Critical reviews in food science and nutrition. 2010;50(4):269–280. doi: 10.1080/10408390902773037. [DOI] [PubMed] [Google Scholar]
- 10.Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertility and sterility. 1988;49(1):112–117. doi: 10.1016/s0015-0282(16)59660-5. [DOI] [PubMed] [Google Scholar]
- 11.Afeiche MC, Gaskins AJ, Williams PL, Toth TL, Wright DL, Tanrikut C, et al. Processed meat intake is unfavorably and fish intake favorably associated with semen quality indicators among men attending a fertility clinic. The Journal of nutrition. 2014;144(7):1091–1098. doi: 10.3945/jn.113.190173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chavarro JE, Toth TL, Wright DL, Meeker JD, Hauser R. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertility and sterility. 2010;93(7):2222–2231. doi: 10.1016/j.fertnstert.2009.01.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. The American journal of clinical nutrition. 1999;69(2):243–249. doi: 10.1093/ajcn/69.2.243. [DOI] [PubMed] [Google Scholar]
- 14.Weber C, Bysted A, Holmer G. Coenzyme Q10 in the diet--daily intake and relative bioavailability. Molecular aspects of medicine. 1997;18(Suppl):S251–S254. doi: 10.1016/s0098-2997(97)00003-4. [DOI] [PubMed] [Google Scholar]
- 15.Kamei M, Fujita T, Kanbe T, Sasaki K, Oshiba K, Otani S, et al. The distribution and content of ubiquinone in foods. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung Journal international de vitaminologie et de nutrition. 1986;56(1):57–63. [PubMed] [Google Scholar]
- 16.Mattila P, Kumpulainen J. Coenzymes Q9and Q10: Contents in Foods and Dietary Intake. Journal of Food Composition and Analysis. 2001;14(4):409–417. DOI: http://dx.doi.org/10.1006/jfca.2000.0983. [Google Scholar]
- 17.Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Human reproduction update. 2010;16(3):231–245. doi: 10.1093/humupd/dmp048. [DOI] [PubMed] [Google Scholar]
- 18.World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th. Geneva: World Health Organization; 2010. p. xiv.p. 271. [Google Scholar]
- 19.Crane FL. Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition. 2001;20(6):591–598. doi: 10.1080/07315724.2001.10719063. [DOI] [PubMed] [Google Scholar]
- 20.Agarwal A, Tvrda E, Sharma R. Relationship amongst teratozoospermia, seminal oxidative stress and male infertility. Reproductive biology and endocrinology : RB&E. 2014;12:45. doi: 10.1186/1477-7827-12-45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Agarwal A, Sharma RK, Sharma R, Assidi M, Abuzenadah AM, Alshahrani S, et al. Characterizing semen parameters and their association with reactive oxygen species in infertile men. Reproductive biology and endocrinology : RB&E. 2014;12:33. doi: 10.1186/1477-7827-12-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Safarinejad MR. The effect of coenzyme Q(1)(0) supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an openlabel prospective study. International urology and nephrology. 2012;44(3):689–700. doi: 10.1007/s11255-011-0081-0. [DOI] [PubMed] [Google Scholar]
- 23.Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. The Journal of urology. 2009;182(1):237–248. doi: 10.1016/j.juro.2009.02.121. [DOI] [PubMed] [Google Scholar]
- 24.Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertility and sterility. 2009;91(5):1785–1792. doi: 10.1016/j.fertnstert.2008.02.119. [DOI] [PubMed] [Google Scholar]
- 25.Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. The Journal of urology. 2012;188(2):526–531. doi: 10.1016/j.juro.2012.03.131. [DOI] [PubMed] [Google Scholar]
- 26.Zita C, Overvad K, Mortensen SA, Sindberg CD, Moesgaard S, Hunter DA. Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study. BioFactors. 2003;18(1–4):185–193. doi: 10.1002/biof.5520180221. [DOI] [PubMed] [Google Scholar]
- 27.Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion. 2007;7(Suppl):S78–S88. doi: 10.1016/j.mito.2007.03.003. [DOI] [PubMed] [Google Scholar]
